InvestorsHub Logo

faithabides

02/05/20 9:56 PM

#182618 RE: dragon_silk #182616

While I do agree no buyout is coming soon. First delivery will have to come first. And, so, the very earliest falls now to Summer 2020 and, yes, it is much more likely now than before the failure to see that buyout in 2021. Where I disagree vigorously is the buyout premium. Once mass production is proven with 1st delivery with payment, then, the buyout premium will in all likelihood greatly exceed the 50-100% norm of a premium. I believe this premium will be an outlier like the one in the link below. Disruptive technology has to dealt with and a bidding war will likely ensue.

Another thing that I believe is that this will be a buyout in part(s) and not whole. The spidersilk piece will go first. But, once the patent applications are approved for the new stuff PR’d last year (see May 22nd and Dec 9th PR), that too could be sold.

Don’t know how all this will all be structured but shareholders will be rewarded immensely imo. I could see a pre-RS $3-5 buyout just for the spidersilk piece. The new stuff might have more value though than that even.


https://www.marketwatch.com/story/allergan-is-paying-a-stunning-500-premium-to-buy-a-clinical-stage-biotech-2016-09-20